These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11867736)

  • 41. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion.
    D'Souza WN; Lefrançois L
    J Immunol; 2003 Dec; 171(11):5727-35. PubMed ID: 14634080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion.
    Ye Z; Xu S; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2008 Apr; 5(2):147-52. PubMed ID: 18445345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An essential role for the IL-2 receptor in T
    Chinen T; Kannan AK; Levine AG; Fan X; Klein U; Zheng Y; Gasteiger G; Feng Y; Fontenot JD; Rudensky AY
    Nat Immunol; 2016 Nov; 17(11):1322-1333. PubMed ID: 27595233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A regulatory T cell-dependent novel function of CD25 (IL-2Ralpha) controlling memory CD8(+) T cell homeostasis.
    Sharma R; Zheng L; Deshmukh US; Jarjour WN; Sung SS; Fu SM; Ju ST
    J Immunol; 2007 Feb; 178(3):1251-5. PubMed ID: 17237369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2).
    Nguyen CL; Salem ML; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    Vaccine; 2003 Jun; 21(19-20):2318-28. PubMed ID: 12744862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses.
    D'Souza WN; Schluns KS; Masopust D; Lefrançois L
    J Immunol; 2002 Jun; 168(11):5566-72. PubMed ID: 12023352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.
    Wolkers MC; Gerlach C; Arens R; Janssen EM; Fitzgerald P; Schumacher TN; Medema JP; Green DR; Schoenberger SP
    Blood; 2012 Jan; 119(3):798-804. PubMed ID: 22128144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autocrine and paracrine IL-2 signals collaborate to regulate distinct phases of CD8 T cell memory.
    Toumi R; Yuzefpolskiy Y; Vegaraju A; Xiao H; Smith KA; Sarkar S; Kalia V
    Cell Rep; 2022 Apr; 39(2):110632. PubMed ID: 35417685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-2 receptor signaling: at the interface between tolerance and immunity.
    Malek TR; Castro I
    Immunity; 2010 Aug; 33(2):153-65. PubMed ID: 20732639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SUSD2 suppresses CD8
    Zhao B; Gong W; Ma A; Chen J; Velegraki M; Dong H; Liu Z; Wang L; Okimoto T; Jones DM; Lei YL; Long M; Oestreich KJ; Ma Q; Xin G; Carbone DP; He K; Li Z; Wen H
    Nat Immunol; 2022 Nov; 23(11):1588-1599. PubMed ID: 36266363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-2 sensitivity and exogenous IL-2 concentration gradient tune the productive contact duration of CD8(+) T cell-APC: a multiscale modeling study.
    Gao X; Arpin C; Marvel J; Prokopiou SA; Gandrillon O; Crauste F
    BMC Syst Biol; 2016 Aug; 10(1):77. PubMed ID: 27535120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of growth factors to modulate the activities of antigen-specific CD8+ T cells in vitro.
    Alenzi FQ; Alenazi FA; Al-Kaabi Y; Salem ML
    J Med Life; 2011 Nov; 4(4):399-406. PubMed ID: 22514573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling.
    Moro A; Gao Z; Wang L; Yu A; Hsiung S; Ban Y; Yan A; Sologon CM; Chen XS; Malek TR
    Nat Immunol; 2022 May; 23(5):802-813. PubMed ID: 35449416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-2 as immunotherapeutic in the autoimmune diseases.
    Orozco Valencia A; Camargo Knirsch M; Suavinho Ferro E; Antonio Stephano M
    Int Immunopharmacol; 2020 Apr; 81():106296. PubMed ID: 32058934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival and division fate programs are preserved but retuned during the naïve to memory CD8
    Heinzel S; Cheon H; Belz GT; Hodgkin PD
    Immunol Cell Biol; 2024 Jan; 102(1):46-57. PubMed ID: 37840018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caspase-3 is transiently activated without cell death during early antigen driven expansion of CD8(+) T cells in vivo.
    McComb S; Mulligan R; Sad S
    PLoS One; 2010 Dec; 5(12):e15328. PubMed ID: 21203525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. XIAP promotes the expansion and limits the contraction of CD8 T cell response through cell extrinsic and intrinsic mechanisms respectively.
    Thakker P; Ariana A; Hajjar S; Cai D; Rijal D; Sad S
    PLoS Pathog; 2023 Jun; 19(6):e1011455. PubMed ID: 37347786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential role of "Signal 3" inflammatory cytokines in regulating CD8 T cell expansion and differentiation in vivo.
    Pham NL; Badovinac VP; Harty JT
    Front Immunol; 2011; 2():4. PubMed ID: 22566795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineering T cell memory for antitumor immunity.
    Bhuiyan AM; Dougan M
    Trends Pharmacol Sci; 2022 Jan; 43(1):1-3. PubMed ID: 34785086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exogenous amino acids are essential for interleukin-7 induced CD8 T cell growth. [corrected].
    Pearson C; Silva A; Seddon B
    PLoS One; 2012; 7(4):e33998. PubMed ID: 22529903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.